WhiteLab Genomics
WhiteLab Genomics uses AI to design genetic medicines and develop bio-assets for cell, RNA and DNA therapies.
$26MSeries B
ParticipantActivity from announced rounds
WhiteLab Genomics uses AI to design genetic medicines and develop bio-assets for cell, RNA and DNA therapies.
Develops multi-state fusion technology for medical radioisotopes and commercial applications
Develops wholesale space infrastructure for telecom operators to provide high-speed internet access